BILT Nutraceuticals was born from the realization that the bewildering amount of choice in the supplement market often overwhelms consumers, making wellness complicated rather than accessible.

Our founders envisioned a brand that simplifies wellness through expertly curated, clean and purpose-driven supplements. BILT serves a higher mission of promoting intentional wellness, enabling consumers to take control of their health with clarity and confidence.

Beyond providing supplements, BILT creates sustainable packaging in harmony with nature, inspires a balanced lifestyle, empowering people to lead fulfilling, healthier lives. We aim to make a significant global impact by setting a new standard in quality, trust, and science-backed supplementation

Act, don’t react.

There is a shift in the way we see health.

Our mission is to build a strong foundation for long-term health, actively preventing chronic ailments instead of merely treating symptoms with medication. We empower individuals to take control of their wellness before problems arise.

All statements and representations provided below describe the parent company, BILT Groupe. The Regulation CF offering itself is for securities issued by Van Der BILT Labs LLC, the subsidiary.

• Launched our first curated set, the Mind Collection, consisting of RISE, FOCUS, and CALM, designed to provide targeted support for energy, focus, and relaxation.
• Secured €155,000 in funding from 3 private investors, demonstrating strong confidence in our vision and strategy. 
• Generated €50,000 revenue from e-commerce prototype test within 9 months.
• Achieved a 75% monthly revenue growth rate during the initial test phase.
• 6 additional collections with 18 products ready for market launch, with manufacturing partnerships secured in Germany and Austria.
• Projected Year 5 revenue of €55.6 million with a 67% gross margin/36% EBITDA margin.

Strategic Relationships & Market Expansion

• GOCO Hospitality collaboration – BILT products to be featured in flagship spas, including the Four Seasons Resort Koh Samui (HBO’s The White Lotus). Positioned to become a foundational partner in GOCO’s new global spa service platform spanning 42+ countries and ultra-high-net-worth clients.
• Stanford Genetics alliance – Chair of Genetics at Stanford and renowned biotech entrepreneur, advising BILT on personalized nutraceuticals integrating epigenetics and methylation data. His expertise strengthens R&D, proprietary IP, and innovation pipeline.
• China market entry – Membership in the Deutsch-Europäisches Zentrum (DEZ), providing regulatory support, wholesale partner access, and local investor connections to accelerate expansion in one of the world’s fastest-growing wellness markets.
• Exclusive global rights with ALYONIQ AG – Secured worldwide online distribution rights for their high-grade, patented microalgae formulations. This agreement ensures access to a unique, contamination-free ingredient platform, supporting differentiation, scalability, and margin control.

Today’s supplement market is saturated, with overwhelming choices and confusing information that leave consumers frustrated and often misinformed. Online supplement sales have grown rapidly, doubling between 2019 and 2022, reflecting a surge in consumer interest. However, navigating the vast array of products and determining the best options for individual health needs remains a significant challenge. Post-pandemic, the trend of self-care and growing skepticism toward traditional healthcare/pharmaceutical industry has accelerated. BILT answers the call for simplicity, democratizing the highest quality and standard, empowering consumers with confidence in their health choices.

The following overviews outline the work and achievements of the parent company, BILT Groupe. While this provides important context, the Regulation CF offering you are considering is for the subsidiary, Van Der BILT Labs LLC.

Wellness, curated.

BILT aspires to be more than a supplement—it’s a trusted partner in each customer's wellness journey, sparking a deep emotional connection through empowerment and genuine care.

Our Plan

Starting in month 25, BILT Nutraceuticals plans to invest in a personalized health diagnostics platform—a natural evolution of our premium supplement collections.

Via our website and app, customers may be able to order at-home test kits for blood panels and/or DNA sampling. These are planned to be analyzed by certified labs and reviewed by health experts, resulting in personalized supplement recommendations based on individual biomarkers and genetic data.

For premium clients, we plan to offer the creation of tailor-made supplements—formulated to match each customer’s specific health profile.

This initiative positions BILT Nutraceuticals as a science-driven wellness companion, integrating diagnostics, expert guidance, and custom formulations. We plan to enable recurring revenue via subscriptions and to reinforce our role at the forefront of luxury, longevity, and personalized health.

We are also embarking on a new development phase in DNA testing and methylation, in collaboration with the Stanford Department of Genetics. BILT is fortunate to have the Chair of Genetics at Stanford and a renowned biotech entrepreneur, as an advisor. He provides expertise on personalized nutraceuticals, focusing on the integration of epigenetics and methylation data, thereby enhancing our R&D, proprietary IP, and innovation pipeline.

One goal. One click.

BILT aims to simplify the overwhelming world of supplements by cutting through the confusion. We aim to make it easy for consumers to know exactly what they need to achieve specific health goals. No overconsumption. No guesswork. No waste.

Luxurious supplements. Made in Germany.

Crafted with pharmaceutical-grade precision, BILT supplements blend scientific rigor with premium quality. Each product is designed to meet the highest standards and strict German production standards, reflecting Germany’s reputation for excellence.

Proven market traction and sales logistics.

Successfully launched the Mind Collection (RISE, FOCUS, CALM) to simplify energy, focus, and relaxation. Secured €155,000 in early funding, signaling investor confidence. Generated €50,000 in prototype sales with a 75% monthly growth rate. Strategic growth in a booming market. With the global nutritional supplement market projected to nearly double in size to $707 billion by 2030, we believe BILT is poised to scale rapidly. Our U.S. entity positions us for early entry into a key growth region, allowing us to circumvent tariffs, with plans for further collections addressing high-demand health areas.

BILT generates revenue through direct-to-consumer sales via online platforms, with a focus on an upcoming Shopify storefront and luxury spas, i.e. Ritz Carlton, Mandarin Oriental, Four Seasons Resort Thailand (as featured on HBO's The White Lotus). Revenue streams include single-product sales and offerings in sets, with flexible subscription options that allow consumers to effortlessly maintain their wellness routines. BILT’s customer-centric model prioritizes convenience and loyalty through supreme quality and thoughtful formulations.

More than a product—a movement.

BILT isn’t just selling supplements; we’re reshaping how people think about wellness. By empowering consumers to make proactive health choices with confidence, we create a lasting impact that resonates far beyond a single transaction.

Join us in building the future of wellness.

This is an opportunity to be part of a company that doesn’t just follow trends—it creates them. BILT is a trusted partner for consumers, an innovator in a growing market, and a brand that delivers clarity in a complex industry. Together, we can redefine health.